Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain
- 18 September 2018
- journal article
- research article
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 126 (1) , 27-33
Abstract
Schizophrenia is a severe, debilitating disorder with a lifetime prevalence of 1% irrespective of gender or ethnicity and is typically treated with antipsychotic drugs. Antipsychotic-induced weight gain (AIWG) is a leading factor of patient non-compliance and has previously been shown to increase the risk of type 2 diabetes, metabolic syndrome, and cardiovascular events. The current study intends to replicate findings from a recent genome-wide association study in Han-Chinese patients implicating two gene variants (rs10977144 and rs10977154) of the protein tyrosine phosphatase receptor type D (PTPRD) in antipsychotic-induced weight gain (AIWG). We investigated a sample of European and African American ancestry (n = 201) and calculated percentage of weight change using linear regression corrected for type of antipsychotics, duration of treatment and principal components from ancestry checks. As secondary goal, we investigated additional gene variants of PTPRD previously not associated with AIWG. We found no association with rs10977144 and rs10977154. However, we found nominally significant results between PTPRD and AIWG with rs73398242 in Europeans (BETA = − 0.267, p = 0.002) and rs13294608 in African Americans (BETA = 0.423, p = 0.003). According to Haploreg, both SNPs are histone marks for enhancers and promoters across various brain regions including the cingulate gyrus and dorsolateral prefrontal cortex. In summary, our results tentatively suggest that PTPRD might be associated with AIWG although different SNPS might be involved in different ethnic groups.Keywords
Funding Information
- Canadian Institutes of Health Research (142192)
This publication has 35 references indexed in Scilit:
- MC4R rs489693: a clinical risk factor for second generation antipsychotic-related weight gain?International Journal of Neuropsychopharmacology, 2013
- Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studiesTranslational Psychiatry, 2013
- A linear complexity phasing method for thousands of genomesNature Methods, 2011
- HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variantsNucleic Acids Research, 2011
- Basic statistical analysis in genetic case-control studiesNature Protocols, 2011
- A map of human genome variation from population-scale sequencingNature, 2010
- Data quality control in genetic case-control association studiesNature Protocols, 2010
- A Genome-Wide Association Study Identifies Susceptibility Variants for Type 2 Diabetes in Han ChinesePLOS Genetics, 2010
- PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage AnalysesThe American Journal of Human Genetics, 2007
- Principal components analysis corrects for stratification in genome-wide association studiesNature Genetics, 2006